Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

review

  • Open Access
    Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification
    SATU NAHKURI and ULRICH H. WEIDLE
    Cancer Genomics & Proteomics September 2025, 22 (5) 654-682; DOI: https://doi.org/10.21873/cgp.20528
  • Open Access
    Association of FOXP3 rs3761548 With Cancer: Systematic Review and Two Approaches of X-chromosome Genotypic Meta-analysis
    CHAROULA ACHILLA, LEFTERIS ANGELIS, THEODOSIOS PAPAVRAMIDIS, ANGELIKI CHORTI and ANTHOULA CHATZIKYRIAKIDOU
    Cancer Genomics & Proteomics September 2025, 22 (5) 683-697; DOI: https://doi.org/10.21873/cgp.20529
  • Open Access
    The Role of ER Stress and the Unfolded Protein Response in Cancer
    ROSE GHEMRAWI, SEDRA KREMESH, WALAA K. MOUSA and MOSTAFA KHAIR
    Cancer Genomics & Proteomics May 2025, 22 (3) 363-381; DOI: https://doi.org/10.21873/cgp.20507
  • Open Access
    Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models
    ULRICH H. WEIDLE and FABIAN BIRZELE
    Cancer Genomics & Proteomics March 2025, 22 (2) 136-165; DOI: https://doi.org/10.21873/cgp.20494
  • Open Access
    The WASP/WAVE Protein Family in Breast Cancer and Their Role in the Metastatic Cascade
    RHIANNON YANNAN YU, WEN G. JIANG and TRACEY A. MARTIN
    Cancer Genomics & Proteomics March 2025, 22 (2) 166-187; DOI: https://doi.org/10.21873/cgp.20495
  • Open Access
    GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target
    KEFAH MOKBEL
    Cancer Genomics & Proteomics November 2024, 21 (6) 549-556; DOI: https://doi.org/10.21873/cgp.20471
  • Open Access
    Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis
    KINAN MOKBEL, MICHAEL WEEDON, VICTORIA MOYE and LEIGH JACKSON
    Cancer Genomics & Proteomics September 2024, 21 (5) 421-438; DOI: https://doi.org/10.21873/cgp.20461
  • Open Access
    CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics July 2024, 21 (4) 327-349; DOI: https://doi.org/10.21873/cgp.20451
  • Open Access
    Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention
    ULRICH H. WEIDLE and FABIAN BIRZELE
    Cancer Genomics & Proteomics May 2024, 21 (3) 213-237; DOI: https://doi.org/10.21873/cgp.20442
  • Open Access
    CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia
    ADAM NOPORA and ULRICH H. WEIDLE
    Cancer Genomics & Proteomics March 2024, 21 (2) 118-136; DOI: https://doi.org/10.21873/cgp.20434

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire